Search
Phibro Animal Health Corp
PAHCAdd to Watchlist
31.850USD
+1.010+3.27%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.29BMarket Cap
13.56P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Phibro Animal Health Corp is 6.00, ranking 132 out of 157 in the Pharmaceuticals industry. The average price target is 45.00, with a high of 50.00 and a low of 32.00.
Analyst Rating
Based on
5
analysts
Hold
Current Rating
42.500
Target Price
+33.44%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Phibro Animal Health Corp
PAHC
5
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Phibro Animal Health Corp's expected revenue for the next quarter?
Phibro Animal Health Corp's expected revenue is 381.25M.
What is Phibro Animal Health Corp's price target?
Analysts forecast that Phibro Animal Health Corp's price target is USD 45.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 32.00.
How have Phibro Animal Health CorpPAHC's recent earnings per share performed?
The market expectation was USD 0.59, while Phibro Animal Health CorpPAHC's earnings per share (EPS) for the previous quarter was USD 0.68. EPS for the next quarter is expected at USD 0.71.
What is the analyst rating for Phibro Animal Health Corp?
Based on the ratings of Phibro Animal Health Corp's stock from 5 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
